Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

被引：0
|
作者：
Huang, H. T. [1 ]
Hawkins, M. A. [1 ,2 ]
Fenwick, J. D. [3 ,4 ]
Nix, M. G. [5 ]
机构：
[1] UCL, Dept Med Phys & Biomed Engn, London, England
[2] CRUK RadNet City London, London, England
[3] Univ Liverpool, Dept Mol & Clin Canc Med, Liverpool, Merseyside, England
[4] Clatterbridge Canc Ctr, Dept Phys, Wirral, Merseyside, England
[5] Leeds Teaching Hosp NHS Trust, Dept Med Phys & Engn, Leeds, W Yorkshire, England
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2840
引用
收藏
页码：E375 / E375
页数：1
相关论文
共 50 条
  • [41] Highlights on immune checkpoint inhibitors in non-small cell lung cancer
    Shen, Meng
    Ren, Xiubao
    TUMOR BIOLOGY, 2017, 39 (03)
  • [42] Neoadjuvant Radiotherapy/Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Yalman, Deniz
    BALKAN MEDICAL JOURNAL, 2015, 32 (01) : 1 - 7
  • [43] Chemoradiotherapy in Elderly Patients with Locally Advanced Non-Small Cell Lung Cancer
    Linhas, Ana
    Dias, Margarida
    Campainha, Sergio
    Conde, Sara
    Barroso, Ana
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S857 - S858
  • [44] Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors
    Murata, Daiki
    Azuma, Koichi
    Matsuo, Norikazu
    Murotani, Kenta
    Matama, Goushi
    Kawahara, Akihiko
    Sasada, Tetsuro
    Tokito, Takaaki
    Hoshino, Tomoaki
    CANCER MEDICINE, 2023, 12 (19): : 19471 - 19479
  • [45] Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer
    Rossi, Emanuela
    Sgambato, Assunta
    De Chiara, Giovanni
    Casaluce, Francesca
    Losanno, Tania
    Sacco, Paola Claudia
    Santabarbara, Giuseppe
    Gridelli, Cesare
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 419 - 428
  • [46] Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
    Manglaviti, Sara
    Brambilla, Marta
    Signorelli, Diego
    Ferrara, Roberto
    Lo Russo, Giuseppe
    Proto, Claudia
    Galli, Giulia
    De Toma, Alessandro
    Occhipinti, Mario
    Viscardi, Giuseppe
    Beninato, Teresa
    Zattarin, Emma
    Bini, Marta
    Lobefaro, Riccardo
    Massa, Giacomo
    Bottiglieri, Achille
    Apollonio, Giulia
    Sottotetti, Elisa
    Di Mauro, Rosa Maria
    Trevisan, Benedetta
    Ganzinelli, Monica
    Fabbri, Alessandra
    de Braud, Filippo G. M.
    Garassino, Marina Chiara
    Prelaj, Arsela
    CLINICAL LUNG CANCER, 2022, 23 (01) : E17 - E28
  • [47] Audit of chemoradiotherapy (CRT) in locally advanced non-small cell lung cancer
    Wong, S. -L.
    Morley, T.
    Meng, K.
    Mahmood, W.
    Forster, M.
    Mendes, R.
    LUNG CANCER, 2015, 87 : S53 - S53
  • [48] Myelosuppression induced by concurrent chemoradiotherapy as a prognostic factor for patients with locally advanced non-small cell lung cancer
    Kishida, Yukiko
    Hirose, Takashi
    Shirai, Takao
    Sugiyama, Tomohide
    Kusumoto, Soujiro
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Adachi, Mitsuru
    Nakamura, Akihiro
    ONCOLOGY LETTERS, 2011, 2 (05) : 949 - 955
  • [49] Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Bergamino, Milana
    Rullan, Antonio J.
    Saigi, Maria
    Peiro, Inmaculada
    Montanya, Eduard
    Palmero, Ramon
    Carlos Ruffinelli, Jose
    Navarro, Arturo
    Dolores Arnaiz, Maria
    Brao, Isabel
    Aso, Samantha
    Padrones, Susana
    Cardenal, Felipe
    Nadal, Ernest
    BMC CANCER, 2019, 19 (1)
  • [50] Concurrent Chemoradiotherapy for Locally Advanced, Unresectable Non-small Cell Lung Cancer: A UK Survey of Current Practice
    Helbrow, J.
    MacNicoll, F.
    Bayman, N.
    Faivre-Finn, C.
    CLINICAL ONCOLOGY, 2012, 24 (08) : E127 - E127
12345